Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2079.76 (Glytoucan)

Id:5032345f-04bd-5e52-8043-40084d8aba1b

Glytoucan:G51464JJ

Results found

Linked to

	Label	Description
	2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000133 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G14371YU-GLYCOSEQ00104375 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G98164UY-GLYCOSEQ00056030 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000159 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G06400QJ-GLYCOSEQ00160635 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G02646YL-GLYCOSEQ00116354 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G46031NV-GLYCOSEQ00171863 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has canonical residue n-glycan a-l-fucp 41 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G24465EF-GLYCOSEQ00034092 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000157 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000133 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G14371YU-GLYCOSEQ00104375 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G98164UY-GLYCOSEQ00056030 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000159 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G06400QJ-GLYCOSEQ00160635 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G02646YL-GLYCOSEQ00116354 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G46031NV-GLYCOSEQ00171863 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has canonical residue n-glycan a-l-fucp 41

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 has glycosequence GLYGEN.GLYCOSEQUENCE:G24465EF-GLYCOSEQ00034092 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2079.76 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000157 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.